Clinical Trials Browser

Phase 1/2 × sapanisertib × Dermatologic × Clear all

NCT02514824 2020-12-29

MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma

Phase 1/2 Completed

9 enrolled 10 charts

Carcinoma, Merkel Cell